title: A correction of misinformation regarding Herbalife.
abstract: The authors of the subject article by Senadhi et al have misrepresented the safety and regulatory status of Herbalife's products. While we are very concerned with the unwarranted and unfavorable publicity that the inaccuracies listed could generate for Herbalife, we would welcome any inquiries that these authors may have to better clarify our commitment to the safety and quality of our products as has been demonstrated in part by our ability to establish positive relationships with regulatory authorities worldwide through continued cooperation and compliance. This letter clarifies the misinformation presented about Herbalife in the subject article.
authors.affiliation: Kristy Appelhans, Raushanah Najeeullah, Vasilios Frankos, Department of Global Product Science Safety and Compliance, Herbalife International of America Inc, Torrance, CA 90502, United States.
authors.forename: Kristy
authors.initials: K
authors.lastname: Appelhans
authors.forename: Raushanah
authors.initials: R
authors.lastname: Najeeullah
authors.forename: Vasilios
authors.initials: V
authors.lastname: Frankos
keywords: Dietary supplements; Drug-induced liver injury; Hepatitis; Herbal; Herbalife